Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 157
Selected: 0
NCT IDTitle
NCT0655759018F-FAPI-04 PET/CT and PET/MR in Patients With Various Types of Malignant Tumors
NCT03624309Anlotinib Plus Docetaxel for the Treatment of EGFR Wild-type Advanced Non-small-cell Lung Cancer
NCT05561686Real-world Study of Pyrotinib in Neoadjuvant Therapy for HER2-positive Breast Cancer
NCT02355249Traditional Three Incisions vs Minimally Invasive Thoracol-laparoscopic Esophagectomy for Esophageal Cancer
NCT07780877Response-adapted Postoperative Radiotherapy In Locally Advanced Head and Neck Cancer
NCT06092957Reduced-dose RT With/Without CCT Versus Standard CCRT for High-risk LANPC Who Achieved CR Post Induction Chemotherapy
NCT05356351An Open-label, Single-arm, Multicenter Phase II Clinical Study: Evaluating RC48-ADC Combined With Triplizumab in the Neoadjuvant Treatment of Her2-positive Muscle-invasive Bladder Cancer
NCT05079074Clinical Application of Circulating Tumor DNA (ctDNA) in Patients With Late-stage Breast Cancer
NCT02448966Traditional Three-incision Esophagectomy Versus Minimally Invasive Thorascopic and Laparoscopic Esophagectomy
NCT03503136Nedaplatin Versus Cisplatin and Capecitabine Versus Fluorouracil in IC + CCRT for Locoregionally Advanced NPC
NCT03994744Assessing Safety and Efficacy of Sintilimab and Metformin Combination Therapy in SCLC
NCT05273944Bioequivalence Study of Doxorubicin Hydrochloride Liposome Injection (Lipodox®) in Chinese Patients
NCT04407988Pyrotinib in Combination With Letrozole in Patients With HER2-Positive, ER-Positive Metastatic Breast Cancer
NCT04974827A Study of Camrelizumab Combined With Concurrent Chemoradiation in Patients With Cervical Cancer
NCT02971345Endovascular Brachytherapy Combined With Stent Placement and TACE for HCC With Main Portal Vein Tumor Thrombus
NCT03880695Anlotinib Hydrochloride Combined With Liposomal Doxorubicin in the Treatment of Locally Advanced or Metastatic Soft Tissue Sarcoma
NCT02395705Neoadjuvant Chemotherapy Versus Surgery Alone for Esophageal Squamous Cell Carcinoma
NCT07584954Phase I, Open-labeled, Dose-escalation, Dose-expansion Study Evaluating the Safety, Tolerance, Pharmacokinetics, and Activity of IUAb190708 in Patients With Advanced or Recurrent Solid Tumors
NCT04922567Efficacy and Safety of Lenalidomide Plus CHOP vs CHOP in Patients With Untreated Peripheral T-Cell Lymphoma
NCT05427617Circulating Tumor DNA (ctDNA)-Guided Late-Line Treatment in Patients With Late-Stage Breast Cancer
NCT05179733The Efficacy and Safety of ZR2 Versus R-miniCHOP in the Treatment of Unfit or Frail de Novo Diffuse Large B-cell Lymphoma Patients Aged Older Than or Equal to 70 Years
NCT05211232Neoadjuvant and Adjuvant Tislelizumab for Nasopharyngeal Carcinoma
NCT06486545Liposomal Irinotecan Combination Regimen for Second-line Treatment of Advanced Gastric Cancer
NCT02958111Single-agent Capecitabine as Adjuvant Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma
NCT06458673A Prospective, Non-interventional Cohort Study of Subsolid Pulmonary Nodules
NCT04823468Effect of Oral Nutritional Supplements on Body Weight Loss of Patients With Nasopharyngeal Carcinoma
NCT07602868A Comparative Study of Delayed Endoscopic DTI and Autologous Flap Reconstruction Post-Mastectomy
NCT07687225Surgery vs. No Surgery for Primary Tumor in De Novo Stage IV Breast Cancer With Solitary Bone Metastases
NCT04030845Patient Report Outcome-Reconstruction and Oncoplastic Cohort
NCT01616849Study of Chemotherapy Combined With Nimotuzumab in Untreated Metastatic Nasopharyngeal Carcinoma
NCT05244499Evidence-based Leadership in Nurse Leaders-CH
NCT04919460Research on Optimization and Evaluation of Oral Cancer Screening Methods
NCT05940532A Trial of Sugemalimab and Chemotherapy in Unresectable Stage III NSCLC
NCT06031376Fruquintinib With PD-1 Inhibitors Versus TAS-102 With Bevacizumab in Late-Line mCRC
NCT05447169Epstein-Barr Virus Antibody and Epstein-Barr Virus DNA for Nasopharyngeal Carcinoma Screening
NCT06022770Clinical Study on Nutrition Intervention in Patients With Esophageal and Gastric Cancer Treated With Chemotherapy
NCT03236649The Phase III Study of Icaritin Versus Sorafenib in PD-L1 Positive Advanced Hepatocellular Carcinoma Subjects
NCT05907447A Retrospective Study on Extranodal Lymphoma or Lymphoma of Rare Pathological Types
NCT06840704Immunonutrition Reduces Acute Esophagitis After Thoracic Radiotherapy in Lung Cancer
NCT05042908Evaluation of LBL-003 Phase I Study in Patients With Advanced Malignancies
NCT05980208A Real-world Study of Inetetamab for First-line Treatment of MBC
NCT04136886Concurrent Chemotherapy for Recurrent T3/T4 Nasopharyngeal Carcinoma
NCT05461690Phase II Study of Niraparib in Metastatic TNBC Patients With Homologous Recombination Deficiency
NCT06561308Clinical Efficacy Study of PD-1 Inhibitor Combined With Neoadjuvant Chemotherapy in Advanced Endometrial Cancer
NCT05460481Anlotinib Plus Penpulimab in Advanced Non-Small-Cell Lung Cancer Previously Treated With PD-1/PD-L1 Inhibitors
NCT04636762A Study of Concurrent Chemoradiation With Atezolizumab in Participants With Untreated Extensive-Stage (ES) Small Cell Lung Cancer (SCLC)
NCT07314216Firmonertinib Combined With Definitive Radiotherapy in Stage III Unresectable EGFR Uncommon Mutant Pulmonary Adenocarcinoma
NCT06748495Real-world First-line Serplulimab-based Immunochemotherapy for Extensive-stage Small Cell Lung Cancer
NCT05869097Trifluridine/Tipiracil Plus Bevacizumab Versus Trifluridine/Tipiracil Monotherapy in Refractory Metastatic Colorectal Cancer
NCT06385990Utidelone (UTD1) Plus Capecitabine in Non-pCR TNBC After Neoadjuvant Therapy